Bochman I would have to politely disagree with your there and I still stand firm on my view of NIL discount.
The wider market has fallen by nearly 7% since GBI traded 90c. Considering the higher beta of biotechs the fall back to 80 has been in line.
What is more promising is that yes 80c appears to be new major support level and it looks like it will soon trade into new territory.
How high is anyone's guess from a technical perspective but I hear a 43-45c run from the 80c level could be on the cards for the next leg up
Rgds
Prof
- Forums
- ASX - By Stock
- GBI
- Ann: Placement
Ann: Placement , page-4
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)